|
UBR5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.765800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.058400E-01 |
| Normal-vs-Stage2 |
8.914000E-01 |
| Normal-vs-Stage3 |
7.014600E-01 |
| Normal-vs-Stage4 |
9.563400E-01 |
| Stage1-vs-Stage2 |
3.618000E-01 |
| Stage1-vs-Stage3 |
4.444200E-01 |
| Stage1-vs-Stage4 |
4.964000E-01 |
| Stage2-vs-Stage3 |
8.381600E-01 |
| Stage2-vs-Stage4 |
9.841600E-01 |
| Stage3-vs-Stage4 |
8.698000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.281600E-01 |
| Normal-vs-AfricanAmerican |
3.124000E-01 |
| Normal-vs-Asian |
7.183400E-01 |
| Caucasian-vs-AfricanAmerican |
9.927000E-01 |
| Caucasian-vs-Asian |
4.790600E-01 |
| AfricanAmerican-vs-Asian |
4.054600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.575230E-01 |
| Normal-vs-Female |
6.505600E-01 |
| Male-vs-Female |
1.165980E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.989600E-01 |
| Normal-vs-Extreme_Weight |
1.394180E-01 |
| Normal-vs-Obese |
6.094000E-01 |
| Normal-vs-Extreme_Obese |
2.869600E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.370800E-01 |
| Normal_Weight-vs-Obese |
8.155400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.652500E-02 |
| Extreme_Weight-vs-Obese |
3.155800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.640230E-01 |
| Obese-vs-Extreme_Obese |
1.083550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.215380E-01 |
| Normal-vs-Age(41-60Yrs) |
8.784400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.756100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.780400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.555700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.102700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.742200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.362400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.918630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.183400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.127600E-01 |
| Normal-VS-Type2 PRCC |
1.007690E-02 |
| Normal-VS-KIRP CIMP |
8.882200E-02 |
| Normal-VS-Unclassified PRCC |
5.981800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.112290E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.803500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.858400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.677740E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.836200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.131900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.208260E-02 |
| Normal-vs-N1 |
5.111400E-01 |
| Normal-vs-N2 |
5.252600E-01 |
| N0-vs-N1 |
1.919820E-02 |
| N0-vs-N2 |
9.259700E-02 |
| N1-vs-N2 |
8.472800E-01 |
|
|
